Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Disease 3Prostatic Neoplasms 2Colorectal Neoplasms 2Sarcoma, Kaposi 1Pain 1Neoplasms 1Lung Neoplasms 1Gynecologic Cancer 1Genetic Diseases, Inborn 1Development of the Virtual Biopsy 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Chronic Pain 1Castleman Disease 1Cancer Pain 1COVID-19 1Breast Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1Adenoma 1

Interventions

Radiosurgery 114Temozolomide 104Bevacizumab 71Radiotherapy 67Magnetic Resonance Spectroscopy 67Carboplatin 29pembrolizumab 28Irinotecan 26Surgical Procedures, Operative 25Radiation 23Nivolumab 23Etoposide 22Magnetic Resonance Imaging 21Ipilimumab 21Erlotinib Hydrochloride 21Cyclophosphamide 21Surveys and Questionnaires 19Aminolevulinic Acid 18Specimen Handling 16Pemetrexed 16Mental Status and Dementia Tests 16Cisplatin 16Carmustine 15Topotecan 14Trastuzumab 13Saline Solution 12Neuropsychological Tests 12Gefitinib 11Filgrastim 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Brain Neoplasms × Diagnostic Tests, Routine × Clear all
NCT06501521 2025-07-18

Non-invasive Brain Tumor Molecular Diagnostics and Monitoring

The Institute of Molecular and Translational Medicine, Czech Republic

Recruiting
200 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡